Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMBI-001 in MYC-Positive Advanced Solid Tumors or Relapsed/Refractory Non-Hodgkin Lymphoma
NCT07864701Phase 2Recruiting
- Sponsor
- Anticancer Bioscience
- Start
- Oct 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of JMBI-001 in solid tumor, non-Hodgkin lymphoma (NHL), sponsored by Anticancer Bioscience. Started Oct 2026; status: recruiting.
02
Drugs
JMBI-001
03
Conditions
solid tumornon-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT07864701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07864701.